{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:53:49Z","timestamp":1788630829027,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.yebeh.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T07:31:24Z","timestamp":1404977484000},"page":"133-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The effects of vagus nerve stimulation on tryptophan metabolites in children with intractable epilepsy"],"prefix":"10.1016","volume":"37","author":[{"given":"S.","family":"Klinkenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.H.","family":"van den Borne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.W.","family":"Aalbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Verschuure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Kessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Leenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Rijkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Aldenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.H.","family":"Vles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.M.","family":"Majoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2014.06.001_bb0015","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1474-4422(02)00220-X","article-title":"Vagus-nerve stimulation for the treatment of epilepsy","volume":"1","author":"Ben-Menachem","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0020","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/FOC\/2008\/25\/9\/E9","article-title":"Vagus nerve stimulation: current concepts","volume":"25","author":"Mapstone","year":"2008","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/nmo.12076","article-title":"Vagus nerve stimulation: from epilepsy to the cholinergic anti\u2010inflammatory pathway","volume":"25","author":"Bonaz","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2009.06.008","article-title":"Effects of vagus nerve stimulation on pro- and anti-inflammatory cytokine induction in patients with refractory epilepsy","volume":"214","author":"De Herdt","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000127360","article-title":"Effect of vagal nerve stimulation on systemic inflammation and cardiac autonomic function in patients with refractory epilepsy","volume":"14","author":"Barone","year":"2007","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000315530","article-title":"Vagus nerve stimulation in refractory epilepsy: effects on pro- and anti-inflammatory cytokines in peripheral blood","volume":"18","author":"Majoie","year":"2011","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.eplepsyres.2008.07.018","article-title":"Do cytokines have any role in epilepsy?","volume":"82","author":"Sinha","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-1211(00)00140-6","article-title":"Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic\u2013clonic seizures","volume":"41","author":"Peltola","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1528-1157.1994.tb02428.x","article-title":"Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures","volume":"35","author":"Heyes","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0060","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0006-8993(10)80038-1","article-title":"Neurochemical effects of vagus nerve stimulation in humans","volume":"583","author":"Hammond","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0920-1211(94)00083-9","article-title":"Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures","volume":"20","author":"Ben-Menachem","year":"1995","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(97)13472-3","article-title":"Pretreatment with l-kynurenine, the precursor to the excitatory amino acid antagonist kynurenic acid, suppresses epileptiform activity in combined entorhinal\/hippocampal slices","volume":"224","author":"Scharfman","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(90)90826-W","article-title":"Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites","volume":"529","author":"Jhamandas","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity","volume":"70","author":"Okuda","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01243276","article-title":"Antagonism of kynurenine-induced seizures by picolinic, kynurenic and xanthurenic acids","volume":"56","author":"Lapin","year":"1983","journal-title":"J Neural Transm"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0006-8993(89)90216-3","article-title":"Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line","volume":"495","author":"Eastman","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12640-009-9034-0","article-title":"5-Hydroxyanthranilic acid, a tryptophan metabolite, generates oxidative stress and neuronal death via p38 activation in cultured cerebellar granule neurones","volume":"15","author":"Smith","year":"2009","journal-title":"Neurotox Res"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0100","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ajpath.2011.05.048","article-title":"The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: role of hemeoxygenase-1","volume":"179","author":"Krause","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0105","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1469-8749.2012.04305.x","article-title":"Vagus nerve stimulation in children with intractable epilepsy: a randomized controlled trial","volume":"54","author":"Klinkenberg","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00004691-200109000-00006","article-title":"Vagus nerve stimulation in children with therapy-resistant epilepsy diagnosed as Lennox\u2013Gastaut syndrome: clinical results, neuropsychological effects, and cost-effectiveness","volume":"18","author":"Majoie","year":"2001","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.seizure.2004.02.003","article-title":"Vagus nerve stimulation in patients with catastrophic childhood epilepsy, a 2-year follow-up study","volume":"14","author":"Majoie","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0120","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.seizure.2006.06.002","article-title":"Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy","volume":"15","author":"Alexopoulos","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.pediatrneurol.2006.06.005","article-title":"Vagus nerve stimulation for intractable seizures in children","volume":"35","author":"Saneto","year":"2006","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.yebeh.2007.10.007","article-title":"Lack of effects of vagus nerve stimulation on drug-resistant epilepsy in eight pediatric patients with autism spectrum disorders: a prospective 2-year follow-up study","volume":"12","author":"Danielsson","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0135","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00381-009-0849-z","article-title":"Vagus nerve stimulation in children with intractable epilepsy: indications, complications and outcome","volume":"25","author":"Kabir","year":"2009","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.seizure.2008.06.010","article-title":"Vagus nerve stimulation in pediatric epileptic syndromes","volume":"18","author":"Rossignol","year":"2009","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/ane.12009","article-title":"Long-term vagus nerve stimulation in children with focal epilepsy","volume":"127","author":"Ryzi","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0887-8994(01)00312-5","article-title":"Vagal nerve stimulation in tuberous sclerosis complex patients","volume":"25","author":"Parain","year":"2001","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.yebeh.2005.05.004","article-title":"Measuring depressive symptoms among treatment-resistant seizure disorder patients: POMS depression scale as an alternative to the BDI-II","volume":"7","author":"Griffith","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0160","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/rcm.4013","article-title":"Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"23","author":"Midttun","year":"2009","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0165","series-title":"Klinische statistiek. Een praktische inleiding in methodologie en analyse","author":"Schouten","year":"1995"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejpn.2012.07.003","article-title":"Behavioural and cognitive effects during vagus nerve stimulation in children with intractable epilepsy \u2014 a randomized controlled trial","volume":"17","author":"Klinkenberg","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0175","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1528-1167.2006.00215.x","article-title":"Report of the ILAE Classification Core Group","volume":"47","author":"Engel","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1196\/annals.1403.003","article-title":"Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging","volume":"1122","author":"Oxenkrug","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0185","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/978-1-4615-0135-0_53","article-title":"Kynurenine pathway enzymes in different species of animals","volume":"527","author":"Allegri","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0190","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/10715760400011437","article-title":"Tryptophan loading induces oxidative stress","volume":"38","author":"Forrest","year":"2004","journal-title":"Free Radic Res"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1212\/WNL.51.1.48","article-title":"Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial","volume":"51","author":"Handforth","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0200","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1212\/WNL.45.2.224","article-title":"A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures","volume":"45","author":"The Vagus Nerve Stimulation Study Group","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0205","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1528-1157.1981.tb04108.x","article-title":"Kynurenines and seizures","volume":"22","author":"Lapin","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0210","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1471-4159.2011.07214.x","article-title":"Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model","volume":"117","author":"Raedt","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1471-4159.1990.tb08857.x","article-title":"Increased cerebrospinal fluid quinolinic acid, kynurenic acid, and l-kynurenine in acute septicemia","volume":"55","author":"Heyes","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2014.06.001_bb0010","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410290215","article-title":"Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status","volume":"29","author":"Heyes","year":"1991","journal-title":"Ann Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014002078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014002078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T14:52:18Z","timestamp":1538405538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505014002078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":42,"alternative-id":["S1525505014002078"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.06.001","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of vagus nerve stimulation on tryptophan metabolites in children with intractable epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}